Results 221 to 230 of about 48,471 (314)
ABSTRACT Rituximab (RTX), an anti‐CD20 monoclonal antibody, has been used to treat autoimmune diseases such as rheumatoid arthritis (RA). However, variability in therapeutic response to RTX remains a challenge. Here, a systems model is developed to mimic B cell differentiation leading to antibody‐secreting cells (ASCs), including plasmablasts (PBs) and
Tomohisa Nakada, Donald E. Mager
wiley +1 more source
IgG4-Related Disease in Urological Practice: A Case Series of Mistaken Malignancies
Mounish Nuthalapati +5 more
openalex +2 more sources
Endoscopic Diagnostics for IgG4-Related Pancreatobiliary Diseases: Current Modalities and Clinical Perspectives [PDF]
Itaru Naitoh +2 more
openalex +1 more source
ABSTRACT Non‐Hodgkin lymphoma (NHL) is the fifth most common malignancy and accounts for 5% of all cancers in the US, with the largest proportion being B‐cell CD20 positive NHL. Odronextamab is a CD20xCD3 IgG4 bispecific T‐cell‐engaging monoclonal antibody under development for the treatment of relapsed or refractory (R/R) B‐NHL. The objectives of this
Marçal Bravo Padros +5 more
wiley +1 more source
New cardiac manifestation of IgG4-related disease: a case report
Marina Pourafkari +5 more
openalex +2 more sources
A Case of IgG4-Related Disease Presenting with Skin Lesions and Proptosis as Initial Manifestations. [PDF]
Wang S, Liu M, Feng Y, Sun D, Zhang H.
europepmc +1 more source
An Overlapping Case of Lupus Nephritis and IgG4-Related Kidney Disease
Mazen Zaarour +4 more
openalex +2 more sources
IgG4-related Disease Presenting as Dural Thickening — A Rare Cause of Myelopathy [PDF]
Jocelyn Zwicker +2 more
openalex +1 more source
Long-term treatment patterns and outcomes in IgG4-related disease - a retrospective single-center cohort study focusing on rituximab. [PDF]
Hammitzsch A +4 more
europepmc +1 more source

